Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02730117Completed
Randomised, open-label trial in acute kidney injury (AKI), sponsored by Chulalongkorn University. Primary endpoint: Renal replacement therapy proportion at 28 days. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02730117.